CN101322867A - Pleoptic instrument for treating ophthalmology department visual disturbance disease - Google Patents
Pleoptic instrument for treating ophthalmology department visual disturbance disease Download PDFInfo
- Publication number
- CN101322867A CN101322867A CNA2008100226835A CN200810022683A CN101322867A CN 101322867 A CN101322867 A CN 101322867A CN A2008100226835 A CNA2008100226835 A CN A2008100226835A CN 200810022683 A CN200810022683 A CN 200810022683A CN 101322867 A CN101322867 A CN 101322867A
- Authority
- CN
- China
- Prior art keywords
- treatment
- square
- disorder disease
- vision enhancer
- visual disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36046—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/04—Eye-masks ; Devices to be worn on the face, not intended for looking through; Eye-pads for sunbathing
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a pleoptic device for curing vision disorder diseases in the ophthalmology department, which comprises an electric pulse generating device (10) used for generating the electric pulse for stimulating vision excitation and delivering visual information and generating visual effects, a pair of electrode plates (20) and a medicine patch (30) that is full of liquid medicine, wherein, the electric pulse generating device (10) is connected with the electrode plates (20) by a guide wire (15) and the electric pulse generated by the electric pulse generating device (10) is conducted onto the medicine patch (30) by the electrode plates (20). The medicine patch (30) contains the liquid medicine with ingredients for curing the vision disorder diseases in the ophthalmology department. The pleoptic device of the invention can effectively cure amblyopia and have a pleoptic effect on the vision disorder diseases in the ophthalmology department, such as cataract, glaucoma, optic atrophy, etc. In addition, the pleoptic device also has the eye health function.
Description
Technical field
The present invention relates to the combine ophthalmic medical instrument of treatment visual disorder oculopathy of a kind of Chinese medicine and modern medicine, relate in particular to a kind of vision enhancer that is used for the treatment of ophthalmology visual disorder diseases such as amblyopia, glaucoma etc., the early stage optic atrophy of optic neuropathy, old sight are degenerated, early stage senile cataract.
Background technology
Amblyopia is in the crowd at present, and especially sickness rate brings many worries for amblyopia eye patient and household than higher among the children.The Therapeutic Method of amblyopia is a lot, for example occlusion therapy, meticulous eyesight coaching method, various composite treatments or the like, but, all have the low shortcoming of cure rate, especially long in the severe cure rate less than 17% and the course of treatment no matter any.
Along with the improvement of national medical health career, people's life-span is prolonging, and senile cataract, glaucoma and optic atrophy become the normal disease of sending out of middle-aged and elderly people, and certain distribution is also arranged in other crowd.At present the senile cataract that is in the period of maturation is mainly recovered lost eyesight by operation, non-period of maturation senile cataract, glaucoma and optic atrophy etc. are not still had effective treatment means.
Summary of the invention
The objective of the invention is: a kind of vision enhancer that is used for the treatment of ophthalmology visual disorder disease is provided, can effectively treats children's amblyopia, and ophthalmic diseasess such as cataract, glaucoma, optic atrophy are had to increase regard usefulness as, also have the eye care effect in addition.
Technical scheme of the present invention is: a kind of herb liquid that is used for imports the vision enhancer for the treatment of ophthalmology visual disorder disease, it comprises---pastes in order to produce electric impulse production device, pair of electrodes plate and the drug application that can excite the patient to look excitement, visual information transmission generation visual effect, described electric impulse production device is by lead connection electrode plate, and the electric pulse that electric impulse production device produces is transmitted to drug application by battery lead plate and pastes; Described drug application is sticked and is contained the medicinal liquid that can treat ophthalmology visual disorder disease.
Below this technical scheme is done further explanation:
The electric pulse of the excited pulse information ripple of described generator generation vision is the multiple harmonic that generates after the square wave of two different pulse frequencies is modulated, one is the low-frequency square-wave pulse in described two square-wave pulses, frequency range is 35～100Hz, another is the high frequency square wave pulse, frequency range is 3500～4500Hz, and two square-wave pulse modulation generate the multiple harmonic of 35～4500Hz later on.As a kind of preferred version: the low-frequency square-wave pulse frequency scope in described two square-wave pulses is 35～100Hz, and high frequency square wave pulse frequency scope is 3500～4000Hz, generates the multiple harmonics of 35～4000Hz after two square-wave pulses modulation.As a kind of more preferably scheme: the low-frequency square-wave pulse frequency scope in two square-wave pulses is 35Hz, and high frequency square wave pulse frequency scope is 4000Hz.
The time that described electric pulse produces can be provided with as required.
Applying ointment or plaster that drug application is pasted can adopt non-woven fabrics or gauze to make applicator material.
Described medicinal liquid is looked soup for increasing, be according to causing visual disorder oculopathy, particularly for the pathology pathogenesis of the primary open angle glaucoma of the low children's moderate and severe degree of amblyopia of cure rate, irreversible inpairment of vision, optic neuropathy, optic atrophy, the decline of old visual function or the like disease, with the pharmacological action of modern Chinese medicine composition, and formulate composition in conjunction with the clinical practice experience in more than 30 years and treat prescription: form by Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei medicine.Utilization Radix Rehmanniae Preparata, Fructus Lycii share have nourishing the liver and kidney, beneficial intensive culture blood, send out actively more to have guaranteed refreshing light, share nourishing the liver to improve visual acuity with Flos Chrysanthemi; The Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, the tonneau passages through which vital energy circulates; Radix Ginseng is the power maximum of QI invigorating, and the gas promoting the circulation of blood is then gone, and makes it to annotate in order on the succinct person of kidney water, then can look all things on earth, and is open infinite.This prescription to what visual sense receiver neurons at different levels, look road, the downtrod children's amblyopia of the visual center, optic neuropathy, optic atrophy, old sight are aging, the treatment of the oculopathy of decline or the like visual disorder, have unique curative effect.
Treatment for open angle glaucoma, the preparation raw material medicated bag of its medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, Flos Carthami, Radix Puerariae, Polyporus, and above crude drug is mixed with 2～4% water preparations that contain medical material weight with the equivalent dose.The damage of glaucoma optic ganglion cell causes vision irreversibility infringement mechanism, and is revealed before 20 years, do not find effective reversibility Therapeutic Method at present yet.Use vision enhancer of the present invention effective ingredient such as Radix Salviae Miltiorrhizae, Radix Puerariae, Flos Carthami are imported eye, blood circulation promoting and blood stasis dispelling, blood vessel dilating, tonneau passages through which vital energy circulates, can effectively reduce intraocular pressure (being better than the timolol effect), share with the Radix Ginseng of QI invigorating power maximum, benefiting QI for activating blood circulation reduces blood viscosity, quicken blood flow, effectively improve amphiblestroid microcirculation, thereby stoped ischemia, anoxia cause the neural excitation toxin release, follow deleterious ion overload or the like, form the vicious cycle of ganglionic cell damage, cause the visual function irreversible lesion.Because this new therapy of vision enhancer has the treatment principle and the function of scientific uniqueness, has effectively stoped retinal ischemia to cause the original position death of retinal ganglial cells, retrieves useful vision, even recovers its normal visual function.
For old man's early cataract, old man's visual deterioration neurocyte reduce, people with visual impairment due to neurotransmission hypofunction or the like, the preparation raw material medicated bag of its medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, Ganoderma, Herba Dendrobii, and above crude drug is mixed with 2～4% water preparations that contain medical material weight with the equivalent dose.Under the ganoderan effect, strengthen anti-aging effects, added with Radix Ginseng, Fructus Lycii and share, increased DNA polymerase alpha active in the cell, thereby promoted the cell proliferation division; Under Radix Ginseng, Fructus Lycii, Ganoderma, the Herba Dendrobii synergism, more strengthened the antioxidant radical effect, effectively removed the damage of oxygen-derived free radicals tissue.Add the pulse information ripple that vision enhancer produces, under the current signal of alternation and the voltage magnitude effect, promote ion and micromolecule transmembrane movement, cell tissue substance transportation and the mass exchange of part tissue of eye cell, thereby prevented that the pathologic retention from appearring in ion in cell.Said medicine imports eye by vision enhancer, has promoted the synthetic of body nucleic acid protein, and cell division, metabolism strengthen, and makes to be in apoptosis originally and near the apoptotic cells recovery, to recover its physiological function, thereby improves visual acuity.
Drug application is pasted when making, will produce the traditional Chinese medicine liquid of special formulation earlier, this traditional Chinese medicine liquid manufacturing process is: section, clean, soak 30 minutes, decocting in water (slow fire two hours), remove slag, filter, be condensed into 1%, modulation, tinning (jar must clean, sterilization, aseptic), cryopreservation.Make and apply ointment or plaster, manufacturing process is: the immersion in medicinal liquid with non-woven fabrics or gauze, pack, vapor sterilization.
The effect of the battery lead plate in the vision enhancer of the present invention (comprising lead) is the electric pulse that electric impulse production device produces to be imported to drug application stick, battery lead plate also should be able to firmly be fixed on the eyelid skin face of closing a state, will wear eyeshield or other device during actual the use battery lead plate and drug application subsides are fixed on the eyes.
Advantage of the present invention is:
1. the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention, have short treating period and characteristics such as evident in efficacy in order to the treatment amblyopia, for example, treat slight amblyopia with vision enhancer of the present invention and generally need 10 days, more rate is generally 96%, and treatment moderate amblyopia generally needs 40 days, and more rate is generally 86%, the treatment moderate and severe degree of amblyopia generally needs 120 days, and more rate is generally 70%.Vision enhancer of the present invention in addition has to increase to ophthalmic diseasess such as cataract, glaucoma, optic atrophys regards usefulness as, also can play the effect of eye care to normal eyes.
2. the vision enhancer that is used for the treatment of ophthalmic diseases of the present invention can produce the excited pulse information ripple of optic nerve, can effectively excite enough look excitement, visual information transmission, produces visual effect.
3. the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention, has the Chinese medicine import feature: because the pulse current of the unidirectional alternation of genus what that vision enhancer takes place, the branch of no both positive and negative polarity, negative ions in the medicine all can import, even bigger molecule also can import, and it is more darker to import dose.
4. the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention improves partial blood circulation, and the open quantity of blood capillary increases, and blood flow is accelerated.Add medicine (as Radix Salviae Miltiorrhizae, Flos Carthami) blood circulation promoting and blood stasis dispelling, blood vessel dilating, minimizing blood viscosity, quicken blood flow, can improve amphiblestroid microcirculation effectively.
5. the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention, physiological action with Pulse Electric: under the effect of the alternating impulse signal of telecommunication and voltage magnitude, promote the electrical activity of part tissue of eye cell, ion and micromolecule transmembrane movement, thereby strengthened cell tissue substance transportation and mass exchange, prevented that the pathologic retention from appearring in ion in cell.Add drug action, the metabolism of body has strengthened, and has promoted body nucleic acid dawn white matter synthetic, and cell division makes to be in apoptosis originally and near the apoptotic cells recovery, to recover its physiological function.
6. the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention, has the effect of acusector moxibustion sample: through the impulse wave of vision enhancer modulation output, look introducing matter to act on order be all acupuncture points by increasing, the effect of the countless acusector moxibustion sample of picture, cause the eye amphotonia, promote the ocular blood circulation, metabolism strengthens.
7. the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention has short treating period and characteristics such as evident in efficacy in order to the oculopathy of treatment visual disorder.
Description of drawings
The invention will be further described below in conjunction with drawings and Examples:
Fig. 1 is a structural representation of the present invention;
Fig. 2 is the theory diagram of electric impulse production device of the present invention.
Wherein: 10 electric impulse production devices; 11 oscillating impulses produce circuit; 12 oscillating impulse amplification output circuits; 13 timing control circuits; 14 direct current regulation circuits; 15 leads; 20 battery lead plates; 30 drug applications are pasted.
The specific embodiment
Embodiment one:
As shown in Figure 1, a kind of vision enhancer that is used for the treatment of ophthalmic diseases, it comprises electric impulse production device 10, pair of electrodes plate 20 and drug application subsides 30.Electric impulse production device 10 is by lead 15 connection electrode plates 20, and the electric pulse that electric impulse production device 10 produces imports to by battery lead plate 20 and soaks drug application subsides 30.During use, the drug application that is soaked with the medicinal liquid of the corresponding ophthalmic diseases of treatment is pasted 30 apply on the eyelid surface that is in closed-eye state, again that two positive-negative electrode plates 20 are placed on it, then the negative ions of medicine can be imported the body part, thereby give full play to drug effect, promote the body rehabilitation.
As shown in Figure 2, electric impulse production device 10 includes: oscillating impulse produces circuit 11, oscillating impulse amplification output circuit 12, timing control circuit 13 and direct current regulation circuit 14.
The electric pulse that oscillating impulse generation circuit 11 produces is the multiple harmonic that generates after the square wave of two different pulse frequencies is modulated, one is the low-frequency square-wave pulse in two square-wave pulses, frequency range is 35Hz, another is the high frequency square wave pulse, frequency range is 4000Hz, and two square-wave pulse modulation generate the multiple harmonic of 35～4000Hz later on.
In order to reach the requirement of treatment effect, oscillating impulse amplification output circuit 12 is amplified to 0～15V to faint pulse information, and battery lead plate 20 electric current densities are 0～0.66mA/cm
2Be passed to then on the battery lead plate 20.
For the needs for the treatment of, the intensity of this pulse can be controlled, to adapt to the needs of Different Individual, so above-mentioned signal is sent to oscillating impulse amplification output circuit 12, through oscillating impulse amplification output circuit 12 faint pulse signal is amplified to 100～1000mV, be coupled to again on this vision enhancer positive-negative electrode plate 20, thereby make the alternating impulse information function at eye, will promote to look excitement effectively, and be delivered to the brain visual center and form vision.If at the same time, the drug application that is soaked with the medicinal liquid (as contain increasing of Chinese medicine such as Fructus Lycii, Flos Chrysanthemi, Radix Ginseng, Radix Salviae Miltiorrhizae look soup) of the corresponding disease of treatment is sticked on the eyelid surface that is in slight closed-eye state, again that two electrode plate are placed on it, then medicine can be imported eye, thereby give full play to drug effect, promote the body rehabilitation.
The vision enhancer of present embodiment can utilize the 3.6V direct current, provides stable direct current supply to oscillating impulse generation circuit 11, oscillating impulse amplification output circuit 12, timing control circuit 13.
30 apply ointment or plaster and apply ointment or plaster for non-woven fabrics pasted in drug application.The medicinal liquid of the different pharmaceutical composition that contains the different ophthalmic diseasess of the various visual disorders of treatment on 30 is pasted in drug application, increase the preparation raw material medicated bag of looking decoction liquid in the present embodiment and contain Radix Ginseng, Fructus Lycii, Semen Cuscutae, Radix Rehmanniae Preparata, Flos Chrysanthemi, Radix Salviae Miltiorrhizae, Rhizoma Acori Graminei, above crude drug is mixed with 4% water preparation that contains medical material weight with the equivalent dose, can be used for treating children's amblyopia, the degeneration of old visual function, optic atrophy, and be used for vision care.To soak drug application subsides 30 during use and be attached on the eyes that need treatment, on battery lead plate 20 is pressed in and applies ointment or plaster, open the switch of electric impulse production device 10, and the intensity of regulating electric pulse with the personal considerations.Will wear eyeshield or other device when in addition, reality is used is fixed on battery lead plate 20 and drug application subsides 30 on the eyelid of closure state.
Embodiment two:
The difference of present embodiment and embodiment one is: the preparation raw material medicated bag of medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, Flos Carthami, Radix Puerariae, Polyporus, above crude drug is mixed with 4% water preparation that contains medical material weight with the equivalent dose, can be used for treating open angle glaucoma.
Embodiment three:
The difference of present embodiment and embodiment one is: the preparation raw material medicated bag of described medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, Ganoderma, Herba Dendrobii, above crude drug is mixed with 2% water preparation that contains medical material weight with the equivalent dose, can be used for treating the early-stage senile cataract.
Experimental example:
Juvenile Feng of amblyopia so-and-so, the man, 13 years old, Gao Yao Xian Lian people from pool, first visit on August 4 in 2007, through Comprehensive Treatment half a year, vision enhancer treatment of the present invention is adopted in invalid back.
Vision situation with eyes before the vision enhancer treatment is: right vision 1.5; Left eye naked vision 0.04 corrects defects of vision 0.1, refractive status+3.5DS, astigmatism+0.75DC * 100 °.
Through the treatment of nearly 4 first quarter moon vision enhancer, check on January 1st, 2008, the result is: the left eye naked vision returns to 1.0, corrects defects of vision 1.5.
Certainly, the vision enhancer that is used for the treatment of ophthalmology visual disorder disease of the present invention also can have multiple conversion and remodeling, is not limited to the concrete structure of above-mentioned embodiment.In a word, protection scope of the present invention should comprise those conspicuous to those skilled in the art conversion or substitute and remodeling.
Claims (10)
1. vision enhancer that is used for the treatment of ophthalmology visual disorder disease, it is characterized in that: it comprises in order to produce electric impulse production device (10), pair of electrodes plate (20) and the drug application that can excite the patient to look excitement, visual information transmission generation visual effect pastes (30), described electric impulse production device (10) is by lead (15) connection electrode plate (20), the electric pulse that electric impulse production device (10) produces is transmitted to drug application by battery lead plate (30) and pastes on (30), and the medicinal liquid that contains the ingredient that can treat ophthalmology visual disorder disease on (30) is pasted in described drug application.
2. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: the electric pulse that described electric impulse production device (10) produces is the multiple harmonic that generates after the square wave of two different pulse frequencies is modulated, one is the low-frequency square-wave pulse in described two square-wave pulses, frequency range is 35～100Hz, another is the high frequency square wave pulse, frequency range is 3500～4500Hz, and two square-wave pulse modulation generate the multiple harmonic of 35～4500Hz later on.
3. according to the described vision enhancer that is used for the treatment of ophthalmic diseases of claim 2, it is characterized in that: the low-frequency square-wave pulse frequency scope in described two square-wave pulses is 35～100Hz, high frequency square wave pulse frequency scope is 3500～4000Hz, and two square-wave pulse modulation generate the multiple harmonic of 35～4000Hz later on.
4. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 2, it is characterized in that: the low-frequency square-wave pulse frequency scope in described two square-wave pulses is 35Hz, and high frequency square wave pulse frequency scope is 4000Hz.
5. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: the time that described electric pulse produces can be provided with as required.
6. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: described drug application is pasted applying ointment or plaster of (30) and is applied ointment or plaster for non-woven fabrics.
7. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: described drug application is pasted applying ointment or plaster of (30) and is applied ointment or plaster for gauze.
8. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: the preparation raw material medicated bag of described medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, above crude drug is mixed with 2～4% water preparations that contain medical material weight with the equivalent dose, can be used for treating children's amblyopia, the degeneration of old visual function, optic atrophy, and be used for vision care.
9. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: the preparation raw material medicated bag of described medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, Flos Carthami, Radix Puerariae, Polyporus, above crude drug is mixed with 2～4% water preparations that contain medical material weight with the equivalent dose, can be used for treating open angle glaucoma.
10. according to the described vision enhancer that is used for the treatment of ophthalmology visual disorder disease of claim 1, it is characterized in that: the preparation raw material medicated bag of described medicinal liquid contains Radix Ginseng, Fructus Lycii, Radix Rehmanniae Preparata, Semen Cuscutae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Rhizoma Acori Graminei, Ganoderma, Herba Dendrobii, above crude drug is mixed with 2～4% water preparations that contain medical material weight with the equivalent dose, can be used for treating the early-stage senile cataract.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100226835A CN101322867A (en) | 2008-07-08 | 2008-07-08 | Pleoptic instrument for treating ophthalmology department visual disturbance disease |
| PCT/CN2009/071099 WO2010003327A1 (en) | 2008-07-08 | 2009-03-31 | Vision-improving instrument for curing ophthalmological visual obstruction disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100226835A CN101322867A (en) | 2008-07-08 | 2008-07-08 | Pleoptic instrument for treating ophthalmology department visual disturbance disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101322867A true CN101322867A (en) | 2008-12-17 |
Family
ID=40186663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008100226835A Pending CN101322867A (en) | 2008-07-08 | 2008-07-08 | Pleoptic instrument for treating ophthalmology department visual disturbance disease |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101322867A (en) |
| WO (1) | WO2010003327A1 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010003327A1 (en) * | 2008-07-08 | 2010-01-14 | 李绍极 | Vision-improving instrument for curing ophthalmological visual obstruction disease |
| CN102526341A (en) * | 2012-01-17 | 2012-07-04 | 宁夏医科大学 | Chinese medicine for treating and relaying age-related cataract advancement |
| CN101427961B (en) * | 2008-12-15 | 2013-04-10 | 龙丹 | Pain relieving sterilized electronic plaster instrument for trauma |
| CN104224435A (en) * | 2013-06-20 | 2014-12-24 | 苏州六六视觉科技股份有限公司 | Therapeutic apparatus for treatment of eye diseases |
| CN104225785A (en) * | 2013-06-20 | 2014-12-24 | 苏州六六视觉科技股份有限公司 | Treatment device used for treating visual system diseases |
| CN105796794A (en) * | 2016-05-31 | 2016-07-27 | 刘征 | Acupoint permeation liquid for curing optic atrophy |
| CN105920239A (en) * | 2016-05-31 | 2016-09-07 | 刘征 | Application of traditional Chinese medicine acupuncture point permeation solution in preparation of medicines for treating optic nerve atrophy |
| CN114364354A (en) * | 2019-09-05 | 2022-04-15 | 夏普株式会社 | Method and device for preventing or treating cataract |
| CN114870245A (en) * | 2022-04-15 | 2022-08-09 | 杭州宝尔科技有限公司 | Microcomputer pulse myopia prevention and treatment instrument |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2729304A1 (en) * | 2011-07-08 | 2014-05-14 | Exxonmobil Oil Corporation | Multi-layer films having improved sealing properties |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1065392A (en) * | 1992-01-08 | 1992-10-21 | 深圳中厨股份有限公司武汉新技术公司 | Wide pulse type dc instrument for treatment of myopia |
| CN1810221A (en) * | 2005-01-25 | 2006-08-02 | 李隆献 | Eyesight improving instrument to guide medicine liquid to human eye to treat eye diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2863040Y (en) * | 2005-04-11 | 2007-01-31 | 李隆献 | vision increasing apparatus transmitting medicine fluid for treating ophthalmological disease into eyes |
| CN200998523Y (en) * | 2006-03-09 | 2008-01-02 | 周大志 | Double-channel electronic low-frequency pulse instrument for treating eye disease and chronic diseases |
| CN101322867A (en) * | 2008-07-08 | 2008-12-17 | 李隆献 | Pleoptic instrument for treating ophthalmology department visual disturbance disease |
-
2008
- 2008-07-08 CN CNA2008100226835A patent/CN101322867A/en active Pending
-
2009
- 2009-03-31 WO PCT/CN2009/071099 patent/WO2010003327A1/en active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1065392A (en) * | 1992-01-08 | 1992-10-21 | 深圳中厨股份有限公司武汉新技术公司 | Wide pulse type dc instrument for treatment of myopia |
| CN1810221A (en) * | 2005-01-25 | 2006-08-02 | 李隆献 | Eyesight improving instrument to guide medicine liquid to human eye to treat eye diseases |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010003327A1 (en) * | 2008-07-08 | 2010-01-14 | 李绍极 | Vision-improving instrument for curing ophthalmological visual obstruction disease |
| CN101427961B (en) * | 2008-12-15 | 2013-04-10 | 龙丹 | Pain relieving sterilized electronic plaster instrument for trauma |
| CN102526341A (en) * | 2012-01-17 | 2012-07-04 | 宁夏医科大学 | Chinese medicine for treating and relaying age-related cataract advancement |
| CN104224435A (en) * | 2013-06-20 | 2014-12-24 | 苏州六六视觉科技股份有限公司 | Therapeutic apparatus for treatment of eye diseases |
| CN104225785A (en) * | 2013-06-20 | 2014-12-24 | 苏州六六视觉科技股份有限公司 | Treatment device used for treating visual system diseases |
| CN105796794A (en) * | 2016-05-31 | 2016-07-27 | 刘征 | Acupoint permeation liquid for curing optic atrophy |
| CN105920239A (en) * | 2016-05-31 | 2016-09-07 | 刘征 | Application of traditional Chinese medicine acupuncture point permeation solution in preparation of medicines for treating optic nerve atrophy |
| CN114364354A (en) * | 2019-09-05 | 2022-04-15 | 夏普株式会社 | Method and device for preventing or treating cataract |
| CN114870245A (en) * | 2022-04-15 | 2022-08-09 | 杭州宝尔科技有限公司 | Microcomputer pulse myopia prevention and treatment instrument |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010003327A1 (en) | 2010-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101322867A (en) | Pleoptic instrument for treating ophthalmology department visual disturbance disease | |
| Panhóca et al. | Treatment of facial nerve palsies with laser and endermotherapy: a report of two cases | |
| CN106421695A (en) | Traditional Chinese medicine composition for eye care | |
| CN104224435A (en) | Therapeutic apparatus for treatment of eye diseases | |
| CN103083609B (en) | Traditional Chinese medicine for treating cervical spondylosis, lumbar intervertebral disc herniation and ankylosing spondylitis | |
| CN100459958C (en) | Chinese medicine heat therapy eyeshade and its medicine | |
| CN100534509C (en) | Chinese-medicinal suppository for treating lumbar vertebrae disease and preparation method thereof | |
| CN107678184A (en) | Anion medical science glasses | |
| CN105477783A (en) | Traditional Chinese medicine transdermal introduction plate electrode and physiotherapy instrument for treating cervical vertebra, lumbar vertebra and joint aches | |
| CN201304179Y (en) | Sight enhancing instrument for curing vision disorder disease of the eye | |
| CN105168446A (en) | Traditional Chinese medicinal composition for treating eye diseases, eye beauty adding bag as well as preparation methods of traditional Chinese medicinal composition and eye beauty adding bag | |
| CN103340992A (en) | Eye ointment for adjusting eyesight | |
| CN104474509A (en) | Medicine patch for conditioning eye refraction and preparation method of medicine patch | |
| CN111329915B (en) | Composition for relieving asthenopia of old people and hydrophilic gel thereof | |
| CN100467054C (en) | Chinese-medicinal suppository for treating cervical spondylosis and its preparation | |
| CN203539524U (en) | Therapeutic apparatus treating ophthalmic diseases | |
| CN107050226A (en) | A kind of Chinese herb medicine eye for treating eye visual fatigue disease applies combination paste and preparation method | |
| CN201564666U (en) | Therapeutic apparatus for preventing and curing myopia and for curing presbyopia | |
| CN115227678A (en) | A Chinese medicinal patch for treating hyperosteogeny and bony spur | |
| CN1109786A (en) | Method of manufacturing eyesight-improving bag for navel treatment | |
| CN110507701A (en) | Promote the gel ointment and its massage application method of vision restoration | |
| CN105311400A (en) | Formula for treating unclear vision due to kidney-yin deficiency | |
| CN2219115Y (en) | Pulse medicine therapeutic apparatus for myopia | |
| CN221712492U (en) | Traditional Chinese medicine massage eyeshade with vision relieving function | |
| CN103372183A (en) | Pharmaceutical composition for treating cervical vertebra and lumbar vertebra diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20081217 |